194 related articles for article (PubMed ID: 14695841)
21. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2.
Gezginci MH; Martin AR; Franzblau SG
J Med Chem; 2001 May; 44(10):1560-3. PubMed ID: 11334565
[TBL] [Abstract][Full Text] [Related]
22. Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives.
Kasimogullari BO; Cesur Z
Molecules; 2004 Sep; 9(10):894-901. PubMed ID: 18007490
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis.
Konduri S; Prashanth J; Krishna VS; Sriram D; Behera JN; Siegel D; Rao KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127512. PubMed ID: 32871269
[TBL] [Abstract][Full Text] [Related]
24. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
[TBL] [Abstract][Full Text] [Related]
25. Anti-tubercular and anti-inflammatory activities of azetidin-2-one derivatives and their effects on the activity of Phospholipase A2.
Yerigeri MC; Murari SK; Thimmaiah KN; Math SK; Vishwanath BS
Med Chem; 2008 Mar; 4(2):190-3. PubMed ID: 18336338
[TBL] [Abstract][Full Text] [Related]
26. A bioactive labdane diterpenoid from Curcuma amada and its semisynthetic analogues as antitubercular agents.
Singh S; Kumar JK; Saikia D; Shanker K; Thakur JP; Negi AS; Banerjee S
Eur J Med Chem; 2010 Sep; 45(9):4379-82. PubMed ID: 20584563
[TBL] [Abstract][Full Text] [Related]
27. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
Manikannan R; Venkatesan R; Muthusubramanian S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2010 Dec; 20(23):6920-4. PubMed ID: 20970331
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
29. Bis dihydropyrimidine: synthesis and antimycobacterial activity.
Ali MA; Manogaran E; Govindasamy J; Sellappan V; Pandian S
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):149-53. PubMed ID: 20583864
[TBL] [Abstract][Full Text] [Related]
30. Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.
Samala G; Brindha Devi P; Saxena S; Gunda S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Nov; 24(21):5556-5564. PubMed ID: 27667550
[TBL] [Abstract][Full Text] [Related]
31. 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis.
Bakkestuen AK; Gundersen LL; Langli G; Liu F; Nolsøe JM
Bioorg Med Chem Lett; 2000 Jun; 10(11):1207-10. PubMed ID: 10866382
[TBL] [Abstract][Full Text] [Related]
32. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.
Wächter GA; Davis MC; Martin AR; Franzblau SG
J Med Chem; 1998 Jun; 41(13):2436-8. PubMed ID: 9632376
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds.
Verbitskiy EV; Cheprakova EM; Slepukhin PA; Kravchenko MA; Skornyakov SN; Rusinov GL; Chupakhin ON; Charushin VN
Eur J Med Chem; 2015 Jun; 97():225-34. PubMed ID: 25982331
[TBL] [Abstract][Full Text] [Related]
35. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
36. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring.
Khoje AD; Kulendrn A; Charnock C; Wan B; Franzblau S; Gundersen LL
Bioorg Med Chem; 2010 Oct; 18(20):7274-82. PubMed ID: 20833056
[TBL] [Abstract][Full Text] [Related]
39. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]